Alexander Kaizer
Concepts (473)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Research Design | 11 | 2025 | 1135 | 2.450 |
Why?
| | Bayes Theorem | 12 | 2025 | 433 | 1.750 |
Why?
| | Laryngopharyngeal Reflux | 5 | 2025 | 14 | 1.690 |
Why?
| | Medical Futility | 2 | 2024 | 31 | 1.560 |
Why?
| | Atrioventricular Block | 5 | 2026 | 45 | 1.360 |
Why?
| | Heart Rate, Fetal | 3 | 2026 | 31 | 1.180 |
Why?
| | Models, Statistical | 5 | 2024 | 681 | 1.140 |
Why?
| | Gastroesophageal Reflux | 8 | 2024 | 236 | 1.070 |
Why?
| | Neoplasms | 6 | 2025 | 2875 | 1.000 |
Why?
| | Esophageal Sphincter, Upper | 2 | 2025 | 8 | 0.990 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2026 | 1720 | 0.920 |
Why?
| | Long QT Syndrome | 2 | 2023 | 69 | 0.880 |
Why?
| | Bariatric Surgery | 7 | 2026 | 242 | 0.880 |
Why?
| | Neostigmine | 2 | 2026 | 21 | 0.860 |
Why?
| | Data Interpretation, Statistical | 3 | 2024 | 372 | 0.840 |
Why?
| | Weight Loss | 9 | 2026 | 836 | 0.830 |
Why?
| | Computer Simulation | 4 | 2024 | 1025 | 0.760 |
Why?
| | Ritonavir | 1 | 2022 | 75 | 0.730 |
Why?
| | Humans | 119 | 2026 | 144759 | 0.730 |
Why?
| | Tobacco Products | 2 | 2020 | 84 | 0.700 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 63 | 0.690 |
Why?
| | Obesity, Morbid | 6 | 2020 | 281 | 0.680 |
Why?
| | Fetal Diseases | 5 | 2026 | 191 | 0.670 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 2022 | 239 | 0.640 |
Why?
| | Clinical Trials as Topic | 1 | 2024 | 1053 | 0.580 |
Why?
| | Pediatric Obesity | 8 | 2020 | 637 | 0.580 |
Why?
| | Data Collection | 1 | 2021 | 633 | 0.580 |
Why?
| | Esophageal Achalasia | 3 | 2023 | 29 | 0.570 |
Why?
| | Spinal Cord Stimulation | 3 | 2024 | 8 | 0.570 |
Why?
| | Anaphylaxis | 1 | 2020 | 102 | 0.570 |
Why?
| | Biostatistics | 1 | 2018 | 19 | 0.550 |
Why?
| | Therapeutics | 1 | 2018 | 13 | 0.550 |
Why?
| | Treatment Outcome | 20 | 2026 | 11679 | 0.510 |
Why?
| | Esophageal Motility Disorders | 3 | 2023 | 29 | 0.510 |
Why?
| | Retrospective Studies | 34 | 2026 | 17066 | 0.490 |
Why?
| | Clinical Protocols | 1 | 2018 | 282 | 0.480 |
Why?
| | Antibodies, Antinuclear | 3 | 2022 | 62 | 0.480 |
Why?
| | Prospective Studies | 23 | 2026 | 7990 | 0.470 |
Why?
| | Tobacco Use Disorder | 1 | 2018 | 218 | 0.470 |
Why?
| | Antiviral Agents | 1 | 2022 | 767 | 0.470 |
Why?
| | Ixodidae | 1 | 2015 | 7 | 0.460 |
Why?
| | Analgesics, Opioid | 7 | 2025 | 1143 | 0.450 |
Why?
| | Mucopolysaccharidosis I | 3 | 2019 | 10 | 0.430 |
Why?
| | Manometry | 7 | 2023 | 97 | 0.420 |
Why?
| | Female | 58 | 2026 | 78271 | 0.420 |
Why?
| | Larva | 1 | 2015 | 242 | 0.420 |
Why?
| | Multiple Pulmonary Nodules | 2 | 2026 | 21 | 0.420 |
Why?
| | Pepsin A | 3 | 2023 | 18 | 0.410 |
Why?
| | Sample Size | 3 | 2024 | 123 | 0.400 |
Why?
| | Esophagitis, Peptic | 2 | 2023 | 16 | 0.380 |
Why?
| | Anti-Obesity Agents | 3 | 2019 | 64 | 0.370 |
Why?
| | Adult | 34 | 2026 | 40449 | 0.370 |
Why?
| | Brachial Plexus Block | 2 | 2022 | 2 | 0.370 |
Why?
| | Esophageal pH Monitoring | 5 | 2023 | 22 | 0.370 |
Why?
| | Speech Perception | 2 | 2026 | 91 | 0.360 |
Why?
| | Proton Pump Inhibitors | 6 | 2023 | 109 | 0.350 |
Why?
| | Injections, Spinal | 3 | 2025 | 120 | 0.350 |
Why?
| | Male | 49 | 2026 | 72315 | 0.340 |
Why?
| | Information Dissemination | 2 | 2024 | 223 | 0.340 |
Why?
| | Lung Neoplasms | 4 | 2026 | 2637 | 0.330 |
Why?
| | Enteral Nutrition | 2 | 2025 | 216 | 0.330 |
Why?
| | Obesity | 5 | 2023 | 3077 | 0.330 |
Why?
| | Adaptive Clinical Trials as Topic | 2 | 2022 | 24 | 0.320 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2024 | 340 | 0.320 |
Why?
| | Anesthetics | 2 | 2022 | 99 | 0.310 |
Why?
| | Nerve Block | 3 | 2021 | 103 | 0.310 |
Why?
| | Body Contouring | 2 | 2020 | 7 | 0.310 |
Why?
| | Enzyme Replacement Therapy | 2 | 2019 | 15 | 0.310 |
Why?
| | Probability | 4 | 2023 | 310 | 0.310 |
Why?
| | Analgesia, Epidural | 2 | 2021 | 38 | 0.300 |
Why?
| | Pain Management | 2 | 2025 | 405 | 0.300 |
Why?
| | Saliva | 3 | 2025 | 249 | 0.280 |
Why?
| | Pregnancy | 9 | 2026 | 7190 | 0.280 |
Why?
| | Esophagus | 2 | 2020 | 261 | 0.270 |
Why?
| | Hearing Aids | 3 | 2026 | 93 | 0.270 |
Why?
| | Tomography, X-Ray Computed | 4 | 2026 | 2730 | 0.260 |
Why?
| | Aged | 19 | 2026 | 25913 | 0.260 |
Why?
| | Middle Aged | 22 | 2026 | 35875 | 0.260 |
Why?
| | Intraoperative Neurophysiological Monitoring | 2 | 2024 | 32 | 0.250 |
Why?
| | Surgeons | 2 | 2021 | 339 | 0.250 |
Why?
| | Incidence | 7 | 2026 | 2879 | 0.250 |
Why?
| | Anesthetics, Local | 3 | 2022 | 100 | 0.250 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2026 | 23 | 0.240 |
Why?
| | Nicotine | 2 | 2020 | 331 | 0.240 |
Why?
| | Infant | 10 | 2026 | 10034 | 0.240 |
Why?
| | Hypoventilation | 1 | 2026 | 17 | 0.240 |
Why?
| | Child | 19 | 2025 | 22633 | 0.230 |
Why?
| | Child Language | 1 | 2026 | 21 | 0.230 |
Why?
| | After-Hours Care | 1 | 2025 | 16 | 0.230 |
Why?
| | Bradycardia | 1 | 2026 | 59 | 0.230 |
Why?
| | Cough | 2 | 2024 | 124 | 0.230 |
Why?
| | Predictive Value of Tests | 4 | 2026 | 2115 | 0.230 |
Why?
| | Neuromuscular Blockade | 1 | 2026 | 51 | 0.230 |
Why?
| | Fractures, Multiple | 1 | 2025 | 6 | 0.220 |
Why?
| | Language Development | 1 | 2026 | 60 | 0.220 |
Why?
| | Bupivacaine | 2 | 2022 | 38 | 0.220 |
Why?
| | Micrognathism | 1 | 2025 | 19 | 0.220 |
Why?
| | Pierre Robin Syndrome | 1 | 2025 | 15 | 0.220 |
Why?
| | Osteogenesis, Distraction | 1 | 2025 | 25 | 0.220 |
Why?
| | Mandible | 1 | 2025 | 72 | 0.220 |
Why?
| | Airway Management | 1 | 2025 | 79 | 0.220 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2023 | 250 | 0.210 |
Why?
| | Cancer Pain | 1 | 2025 | 36 | 0.210 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2024 | 16 | 0.210 |
Why?
| | Multicenter Studies as Topic | 2 | 2026 | 405 | 0.210 |
Why?
| | Pregnancy Outcome | 3 | 2023 | 476 | 0.210 |
Why?
| | Infant, Newborn | 7 | 2026 | 6429 | 0.210 |
Why?
| | Body Weight | 2 | 2019 | 976 | 0.210 |
Why?
| | Laparoscopy | 2 | 2020 | 475 | 0.210 |
Why?
| | Biometry | 1 | 2024 | 68 | 0.210 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2024 | 21 | 0.200 |
Why?
| | Patient Reported Outcome Measures | 2 | 2025 | 488 | 0.200 |
Why?
| | Hearing Loss, Sudden | 1 | 2023 | 11 | 0.200 |
Why?
| | Radiation Dosage | 1 | 2025 | 192 | 0.200 |
Why?
| | Myotomy | 1 | 2023 | 15 | 0.200 |
Why?
| | Blood Transfusion | 2 | 2024 | 405 | 0.200 |
Why?
| | Tachycardia, Supraventricular | 1 | 2023 | 45 | 0.190 |
Why?
| | Airway Obstruction | 1 | 2025 | 162 | 0.190 |
Why?
| | Atrial Flutter | 1 | 2023 | 45 | 0.190 |
Why?
| | Intestinal Atresia | 1 | 2023 | 17 | 0.190 |
Why?
| | Intrauterine Devices, Medicated | 1 | 2023 | 27 | 0.190 |
Why?
| | Postoperative Care | 1 | 2025 | 288 | 0.190 |
Why?
| | Vitamin D Deficiency | 1 | 2025 | 186 | 0.190 |
Why?
| | Adolescent | 19 | 2026 | 22428 | 0.190 |
Why?
| | Lopinavir | 1 | 2022 | 30 | 0.190 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2023 | 73 | 0.190 |
Why?
| | Heart Arrest | 2 | 2024 | 407 | 0.190 |
Why?
| | Immunosorbents | 1 | 2022 | 1 | 0.190 |
Why?
| | Lidocaine | 1 | 2023 | 54 | 0.190 |
Why?
| | Intubation, Intratracheal | 1 | 2025 | 320 | 0.190 |
Why?
| | Point-of-Care Systems | 1 | 2024 | 187 | 0.190 |
Why?
| | Neutropenia | 1 | 2023 | 155 | 0.180 |
Why?
| | Fetal Heart | 2 | 2019 | 57 | 0.180 |
Why?
| | Equivalence Trials as Topic | 1 | 2022 | 36 | 0.180 |
Why?
| | Pulmonary Emphysema | 1 | 2025 | 275 | 0.180 |
Why?
| | Current Procedural Terminology | 1 | 2022 | 19 | 0.180 |
Why?
| | Deafness | 1 | 2023 | 78 | 0.180 |
Why?
| | United States | 10 | 2025 | 15966 | 0.180 |
Why?
| | Triage | 1 | 2024 | 249 | 0.180 |
Why?
| | Tympanoplasty | 1 | 2022 | 9 | 0.180 |
Why?
| | Electromyography | 1 | 2024 | 415 | 0.180 |
Why?
| | Weight Gain | 1 | 2026 | 556 | 0.180 |
Why?
| | Tympanic Membrane Perforation | 1 | 2022 | 17 | 0.180 |
Why?
| | Diaphragm | 2 | 2022 | 49 | 0.180 |
Why?
| | Enterocolitis, Neutropenic | 1 | 2021 | 5 | 0.180 |
Why?
| | Tremor | 1 | 2022 | 98 | 0.180 |
Why?
| | Funnel Chest | 1 | 2021 | 29 | 0.170 |
Why?
| | Psychological Trauma | 1 | 2022 | 57 | 0.170 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2022 | 68 | 0.170 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2022 | 133 | 0.170 |
Why?
| | Lung | 3 | 2024 | 4109 | 0.170 |
Why?
| | Vitamin D | 1 | 2025 | 400 | 0.170 |
Why?
| | Nose Neoplasms | 1 | 2021 | 21 | 0.170 |
Why?
| | Eructation | 1 | 2021 | 2 | 0.170 |
Why?
| | Prostate | 1 | 2022 | 158 | 0.170 |
Why?
| | Paranasal Sinus Neoplasms | 1 | 2021 | 29 | 0.170 |
Why?
| | Medicare Part D | 1 | 2021 | 23 | 0.170 |
Why?
| | Epidermolysis Bullosa | 1 | 2022 | 68 | 0.170 |
Why?
| | Telemedicine | 2 | 2021 | 945 | 0.170 |
Why?
| | Congenital Microtia | 1 | 2020 | 8 | 0.170 |
Why?
| | Fetus | 2 | 2023 | 803 | 0.170 |
Why?
| | Hernia, Hiatal | 1 | 2021 | 41 | 0.170 |
Why?
| | Patient Handoff | 1 | 2021 | 42 | 0.170 |
Why?
| | Tumor Burden | 1 | 2022 | 319 | 0.170 |
Why?
| | Prenatal Diagnosis | 2 | 2019 | 195 | 0.170 |
Why?
| | Cystectomy | 1 | 2021 | 41 | 0.170 |
Why?
| | Specialties, Surgical | 1 | 2022 | 82 | 0.160 |
Why?
| | Ear | 1 | 2020 | 31 | 0.160 |
Why?
| | Postoperative Complications | 4 | 2021 | 2919 | 0.160 |
Why?
| | Bias | 1 | 2021 | 202 | 0.160 |
Why?
| | Risk Factors | 11 | 2025 | 10779 | 0.160 |
Why?
| | Body Mass Index | 5 | 2026 | 2438 | 0.160 |
Why?
| | Hepatectomy | 1 | 2023 | 273 | 0.160 |
Why?
| | Ocular Hypertension | 1 | 2021 | 70 | 0.160 |
Why?
| | Shock | 1 | 2021 | 108 | 0.160 |
Why?
| | Biomarkers, Tumor | 2 | 2026 | 1313 | 0.160 |
Why?
| | Spinal Cord Injuries | 1 | 2024 | 240 | 0.160 |
Why?
| | Electrocardiography | 1 | 2023 | 662 | 0.160 |
Why?
| | Magnetocardiography | 1 | 2019 | 2 | 0.160 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 2168 | 0.160 |
Why?
| | Parenteral Nutrition | 1 | 2021 | 105 | 0.150 |
Why?
| | Prevalence | 3 | 2023 | 2834 | 0.150 |
Why?
| | Drug Costs | 1 | 2021 | 116 | 0.150 |
Why?
| | Glaucoma, Open-Angle | 1 | 2021 | 104 | 0.150 |
Why?
| | Congenital Abnormalities | 1 | 2020 | 104 | 0.150 |
Why?
| | Carcinoma | 1 | 2021 | 228 | 0.150 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2026 | 985 | 0.150 |
Why?
| | Substance Abuse Detection | 1 | 2021 | 106 | 0.150 |
Why?
| | Time Factors | 7 | 2026 | 7173 | 0.150 |
Why?
| | Hearing Loss | 1 | 2023 | 247 | 0.150 |
Why?
| | Cochlear Implantation | 1 | 2021 | 82 | 0.150 |
Why?
| | Cochlear Implants | 1 | 2021 | 95 | 0.150 |
Why?
| | Tracheostomy | 1 | 2021 | 142 | 0.150 |
Why?
| | Hyperplasia | 1 | 2020 | 174 | 0.150 |
Why?
| | Kidney Transplantation | 1 | 2026 | 704 | 0.150 |
Why?
| | Spine | 1 | 2021 | 182 | 0.150 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 17 | 0.150 |
Why?
| | Cardiotocography | 1 | 2018 | 5 | 0.150 |
Why?
| | Exercise | 3 | 2020 | 2201 | 0.140 |
Why?
| | Stillbirth | 1 | 2019 | 77 | 0.140 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 64 | 0.140 |
Why?
| | Medically Underserved Area | 1 | 2019 | 101 | 0.140 |
Why?
| | Intra-Abdominal Fat | 1 | 2019 | 100 | 0.140 |
Why?
| | Drug Prescriptions | 1 | 2021 | 284 | 0.140 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2022 | 255 | 0.140 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2018 | 9 | 0.140 |
Why?
| | Abortion, Spontaneous | 1 | 2019 | 115 | 0.140 |
Why?
| | Baths | 1 | 2018 | 13 | 0.140 |
Why?
| | Cell-Derived Microparticles | 1 | 2019 | 75 | 0.140 |
Why?
| | Soaps | 1 | 2018 | 10 | 0.140 |
Why?
| | Child, Preschool | 9 | 2026 | 11787 | 0.140 |
Why?
| | Genotype | 1 | 2023 | 1833 | 0.140 |
Why?
| | Outpatients | 1 | 2022 | 442 | 0.140 |
Why?
| | Nutritional Status | 1 | 2021 | 354 | 0.140 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2018 | 25 | 0.140 |
Why?
| | Anti-Infective Agents, Local | 1 | 2018 | 40 | 0.140 |
Why?
| | Anesthesia | 1 | 2022 | 258 | 0.140 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 428 | 0.140 |
Why?
| | Africa, Western | 1 | 2018 | 21 | 0.140 |
Why?
| | Cannabinoids | 1 | 2020 | 182 | 0.130 |
Why?
| | Disease Models, Animal | 3 | 2024 | 4557 | 0.130 |
Why?
| | Phenotype | 2 | 2023 | 3162 | 0.130 |
Why?
| | Gastroenterology | 1 | 2020 | 189 | 0.130 |
Why?
| | Glaucoma | 1 | 2021 | 250 | 0.130 |
Why?
| | Perioperative Care | 1 | 2020 | 231 | 0.130 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 609 | 0.130 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2017 | 48 | 0.130 |
Why?
| | Anti-Bacterial Agents | 3 | 2024 | 1907 | 0.130 |
Why?
| | Ultrasonography, Prenatal | 1 | 2019 | 294 | 0.130 |
Why?
| | Cross-Sectional Studies | 7 | 2025 | 5868 | 0.130 |
Why?
| | Penicillin Resistance | 1 | 2017 | 8 | 0.130 |
Why?
| | Dyslipidemias | 1 | 2019 | 181 | 0.130 |
Why?
| | Barrett Esophagus | 1 | 2020 | 165 | 0.130 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2018 | 81 | 0.130 |
Why?
| | Cesarean Section | 3 | 2026 | 224 | 0.130 |
Why?
| | Pancreaticoduodenectomy | 1 | 2018 | 135 | 0.130 |
Why?
| | Hypoxia | 2 | 2025 | 1199 | 0.130 |
Why?
| | Serogroup | 1 | 2017 | 44 | 0.130 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2026 | 1180 | 0.130 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 152 | 0.130 |
Why?
| | Child Behavior | 1 | 2019 | 236 | 0.130 |
Why?
| | Disinfection | 1 | 2018 | 129 | 0.130 |
Why?
| | Phentermine | 1 | 2016 | 14 | 0.120 |
Why?
| | Cigarette Smoking | 1 | 2018 | 99 | 0.120 |
Why?
| | Swine | 3 | 2024 | 833 | 0.120 |
Why?
| | Echocardiography | 1 | 2019 | 652 | 0.120 |
Why?
| | Ovarian Neoplasms | 1 | 2022 | 586 | 0.120 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 253 | 0.120 |
Why?
| | Respiration, Artificial | 1 | 2021 | 708 | 0.120 |
Why?
| | Blood Platelets | 1 | 2019 | 400 | 0.120 |
Why?
| | Pneumococcal Infections | 1 | 2017 | 103 | 0.120 |
Why?
| | Fructose | 1 | 2016 | 130 | 0.120 |
Why?
| | Heart-Assist Devices | 1 | 2022 | 567 | 0.120 |
Why?
| | Spinal Cord | 3 | 2024 | 380 | 0.120 |
Why?
| | Pneumonectomy | 1 | 2017 | 169 | 0.120 |
Why?
| | Parkinson Disease | 1 | 2022 | 600 | 0.120 |
Why?
| | Burns | 1 | 2021 | 377 | 0.120 |
Why?
| | Gestational Age | 4 | 2019 | 975 | 0.120 |
Why?
| | Body Composition | 1 | 2019 | 706 | 0.110 |
Why?
| | Internal Medicine | 1 | 2018 | 280 | 0.110 |
Why?
| | Heart Transplantation | 1 | 2022 | 736 | 0.110 |
Why?
| | Pain Measurement | 3 | 2025 | 552 | 0.110 |
Why?
| | Adiposity | 2 | 2019 | 543 | 0.110 |
Why?
| | Missouri | 1 | 2015 | 66 | 0.110 |
Why?
| | Mentoring | 1 | 2018 | 166 | 0.110 |
Why?
| | Meals | 1 | 2016 | 130 | 0.110 |
Why?
| | Reproducibility of Results | 5 | 2021 | 3409 | 0.110 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 248 | 0.110 |
Why?
| | Streptococcus pneumoniae | 1 | 2017 | 177 | 0.110 |
Why?
| | Surgical Wound Infection | 1 | 2018 | 316 | 0.110 |
Why?
| | Faculty, Medical | 1 | 2018 | 302 | 0.110 |
Why?
| | Forests | 1 | 2015 | 58 | 0.110 |
Why?
| | Lung Diseases | 1 | 2022 | 787 | 0.110 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2019 | 675 | 0.110 |
Why?
| | Precision Medicine | 1 | 2019 | 457 | 0.110 |
Why?
| | Suicide | 1 | 2022 | 720 | 0.110 |
Why?
| | Disease Outbreaks | 1 | 2018 | 422 | 0.110 |
Why?
| | Length of Stay | 4 | 2021 | 1337 | 0.110 |
Why?
| | Critical Illness | 1 | 2021 | 891 | 0.110 |
Why?
| | Epinephrine | 2 | 2026 | 155 | 0.100 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 6048 | 0.100 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2022 | 893 | 0.100 |
Why?
| | Pilot Projects | 4 | 2021 | 1886 | 0.100 |
Why?
| | Cognitive Dysfunction | 1 | 2019 | 461 | 0.100 |
Why?
| | Hypertension | 1 | 2022 | 1263 | 0.100 |
Why?
| | Wounds and Injuries | 1 | 2022 | 956 | 0.100 |
Why?
| | Veterans | 2 | 2022 | 1603 | 0.100 |
Why?
| | Feeding Behavior | 1 | 2019 | 684 | 0.100 |
Why?
| | Cannabis | 1 | 2020 | 509 | 0.100 |
Why?
| | Mothers | 1 | 2019 | 775 | 0.100 |
Why?
| | Esophagogastric Junction | 2 | 2023 | 55 | 0.100 |
Why?
| | Muscle Spasticity | 2 | 2023 | 63 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 965 | 0.100 |
Why?
| | Pregnancy Complications | 1 | 2018 | 592 | 0.090 |
Why?
| | Minnesota | 3 | 2018 | 169 | 0.090 |
Why?
| | Medicare | 3 | 2024 | 886 | 0.090 |
Why?
| | Quality of Life | 1 | 2025 | 3185 | 0.090 |
Why?
| | Opioid-Related Disorders | 1 | 2021 | 600 | 0.090 |
Why?
| | Animals | 5 | 2024 | 38058 | 0.090 |
Why?
| | Physicians | 1 | 2021 | 939 | 0.090 |
Why?
| | Seasons | 1 | 2015 | 556 | 0.090 |
Why?
| | Clinical Competence | 1 | 2020 | 1244 | 0.090 |
Why?
| | Electric Impedance | 2 | 2023 | 111 | 0.090 |
Why?
| | Insulin Resistance | 1 | 2020 | 1241 | 0.090 |
Why?
| | Hospitalization | 1 | 2022 | 2433 | 0.090 |
Why?
| | Heartburn | 2 | 2021 | 12 | 0.090 |
Why?
| | Heart Defects, Congenital | 1 | 2019 | 914 | 0.090 |
Why?
| | Monitoring, Ambulatory | 2 | 2023 | 88 | 0.090 |
Why?
| | Mental Health | 1 | 2018 | 790 | 0.090 |
Why?
| | Internship and Residency | 1 | 2022 | 1257 | 0.080 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2023 | 561 | 0.080 |
Why?
| | ROC Curve | 2 | 2024 | 614 | 0.080 |
Why?
| | Intensive Care Units | 3 | 2021 | 916 | 0.080 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 2194 | 0.080 |
Why?
| | Cognition | 1 | 2019 | 1266 | 0.080 |
Why?
| | Anxiety | 1 | 2018 | 1109 | 0.080 |
Why?
| | Cohort Studies | 4 | 2021 | 5960 | 0.080 |
Why?
| | Longitudinal Studies | 3 | 2026 | 2947 | 0.080 |
Why?
| | Ecosystem | 1 | 2015 | 589 | 0.080 |
Why?
| | Operating Rooms | 2 | 2022 | 146 | 0.080 |
Why?
| | Operative Time | 2 | 2022 | 175 | 0.070 |
Why?
| | Tertiary Care Centers | 2 | 2022 | 189 | 0.070 |
Why?
| | Medical Oncology | 2 | 2022 | 332 | 0.070 |
Why?
| | Hemodynamics | 2 | 2024 | 1121 | 0.070 |
Why?
| | Prognosis | 3 | 2023 | 4282 | 0.070 |
Why?
| | Ultrasonography, Interventional | 2 | 2021 | 160 | 0.070 |
Why?
| | Depression | 1 | 2018 | 1558 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2023 | 1985 | 0.070 |
Why?
| | Double-Blind Method | 2 | 2026 | 2029 | 0.060 |
Why?
| | Anesthesia Recovery Period | 1 | 2026 | 29 | 0.060 |
Why?
| | Speech Discrimination Tests | 1 | 2026 | 6 | 0.060 |
Why?
| | Neuromuscular Nondepolarizing Agents | 1 | 2026 | 32 | 0.060 |
Why?
| | Phonetics | 1 | 2026 | 40 | 0.060 |
Why?
| | Cholinesterase Inhibitors | 1 | 2026 | 46 | 0.060 |
Why?
| | Umbilical Cord | 1 | 2026 | 91 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2021 | 5408 | 0.060 |
Why?
| | Preoperative Period | 1 | 2026 | 149 | 0.060 |
Why?
| | Feasibility Studies | 2 | 2022 | 1095 | 0.060 |
Why?
| | Speech | 1 | 2026 | 77 | 0.060 |
Why?
| | Algorithms | 2 | 2024 | 1837 | 0.050 |
Why?
| | Decompression | 1 | 2024 | 3 | 0.050 |
Why?
| | Mice | 1 | 2022 | 18339 | 0.050 |
Why?
| | False Negative Reactions | 1 | 2024 | 60 | 0.050 |
Why?
| | Registries | 2 | 2025 | 2385 | 0.050 |
Why?
| | Uncertainty | 1 | 2025 | 144 | 0.050 |
Why?
| | Monitoring, Intraoperative | 1 | 2024 | 64 | 0.050 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2025 | 121 | 0.050 |
Why?
| | Disease Progression | 2 | 2024 | 2847 | 0.050 |
Why?
| | Ventricular Fibrillation | 1 | 2024 | 64 | 0.050 |
Why?
| | Quality Control | 1 | 2024 | 163 | 0.050 |
Why?
| | Neck | 1 | 2024 | 108 | 0.050 |
Why?
| | Laryngeal Diseases | 1 | 2024 | 31 | 0.050 |
Why?
| | Patient Positioning | 1 | 2024 | 70 | 0.050 |
Why?
| | Hydrops Fetalis | 1 | 2023 | 13 | 0.050 |
Why?
| | Larynx | 1 | 2024 | 56 | 0.050 |
Why?
| | Digoxin | 1 | 2023 | 27 | 0.050 |
Why?
| | Esophageal Sphincter, Lower | 1 | 2023 | 14 | 0.050 |
Why?
| | Tachycardia | 1 | 2023 | 57 | 0.050 |
Why?
| | Caregivers | 2 | 2023 | 1049 | 0.050 |
Why?
| | Anesthesia, General | 1 | 2024 | 118 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2021 | 3604 | 0.050 |
Why?
| | Pandemics | 2 | 2022 | 1694 | 0.050 |
Why?
| | Edema | 1 | 2023 | 124 | 0.050 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2023 | 142 | 0.050 |
Why?
| | Fingers | 1 | 2022 | 107 | 0.040 |
Why?
| | Coronary Artery Bypass | 1 | 2024 | 268 | 0.040 |
Why?
| | False Positive Reactions | 1 | 2022 | 121 | 0.040 |
Why?
| | Proton Pumps | 1 | 2021 | 8 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2022 | 174 | 0.040 |
Why?
| | Patients | 1 | 2023 | 180 | 0.040 |
Why?
| | Rotator Cuff | 1 | 2022 | 59 | 0.040 |
Why?
| | Goals | 1 | 2023 | 183 | 0.040 |
Why?
| | Motor Skills | 1 | 2022 | 104 | 0.040 |
Why?
| | Malawi | 1 | 2021 | 57 | 0.040 |
Why?
| | Prostheses and Implants | 1 | 2022 | 141 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2022 | 521 | 0.040 |
Why?
| | Tonometry, Ocular | 1 | 2021 | 103 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2023 | 222 | 0.040 |
Why?
| | Hearing Loss, Conductive | 1 | 2020 | 24 | 0.040 |
Why?
| | Benchmarking | 1 | 2022 | 188 | 0.040 |
Why?
| | Ultrasonography | 1 | 2024 | 770 | 0.040 |
Why?
| | Gastrointestinal Agents | 1 | 2021 | 66 | 0.040 |
Why?
| | Fitness Trackers | 1 | 2020 | 16 | 0.040 |
Why?
| | Noise | 1 | 2021 | 71 | 0.040 |
Why?
| | United Arab Emirates | 1 | 2020 | 7 | 0.040 |
Why?
| | Accidental Falls | 1 | 2023 | 222 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2023 | 281 | 0.040 |
Why?
| | Iduronidase | 1 | 2019 | 3 | 0.040 |
Why?
| | Risk Assessment | 2 | 2020 | 3671 | 0.040 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2019 | 7 | 0.040 |
Why?
| | Los Angeles | 1 | 2020 | 76 | 0.040 |
Why?
| | Abdominoplasty | 1 | 2019 | 7 | 0.040 |
Why?
| | Waist Circumference | 1 | 2020 | 139 | 0.040 |
Why?
| | Fundoplication | 1 | 2020 | 54 | 0.040 |
Why?
| | Competency-Based Education | 1 | 2020 | 79 | 0.040 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2019 | 21 | 0.040 |
Why?
| | Iron | 1 | 2022 | 359 | 0.040 |
Why?
| | Piperidines | 1 | 2021 | 217 | 0.040 |
Why?
| | Biomarkers, Pharmacological | 1 | 2019 | 26 | 0.040 |
Why?
| | Reoperation | 1 | 2022 | 630 | 0.040 |
Why?
| | Fathers | 1 | 2019 | 51 | 0.040 |
Why?
| | Biomarkers | 2 | 2021 | 4271 | 0.040 |
Why?
| | Collagen | 1 | 2022 | 456 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2023 | 535 | 0.040 |
Why?
| | Colorado | 2 | 2019 | 4564 | 0.040 |
Why?
| | Child Abuse | 1 | 2025 | 551 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 462 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 2019 | 74 | 0.040 |
Why?
| | Intraocular Pressure | 1 | 2021 | 328 | 0.040 |
Why?
| | Mupirocin | 1 | 2018 | 7 | 0.040 |
Why?
| | Mouthwashes | 1 | 2018 | 13 | 0.040 |
Why?
| | Heterozygote | 1 | 2019 | 315 | 0.040 |
Why?
| | Hemorrhage | 1 | 2024 | 809 | 0.040 |
Why?
| | Chlorhexidine | 1 | 2018 | 23 | 0.040 |
Why?
| | Endoscopy, Digestive System | 1 | 2020 | 140 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2020 | 779 | 0.040 |
Why?
| | Early Detection of Cancer | 1 | 2023 | 463 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2020 | 267 | 0.030 |
Why?
| | Administration, Intranasal | 1 | 2018 | 93 | 0.030 |
Why?
| | Analgesics | 1 | 2020 | 228 | 0.030 |
Why?
| | Patient Care Bundles | 1 | 2018 | 28 | 0.030 |
Why?
| | Precancerous Conditions | 1 | 2020 | 166 | 0.030 |
Why?
| | Superficial Back Muscles | 1 | 2018 | 16 | 0.030 |
Why?
| | Self Administration | 1 | 2018 | 124 | 0.030 |
Why?
| | Nasal Cavity | 1 | 2018 | 62 | 0.030 |
Why?
| | Catheters | 1 | 2018 | 75 | 0.030 |
Why?
| | Staff Development | 1 | 2018 | 61 | 0.030 |
Why?
| | Carrier State | 1 | 2018 | 79 | 0.030 |
Why?
| | Mortality | 1 | 2020 | 375 | 0.030 |
Why?
| | Chronic Disease | 1 | 2024 | 1813 | 0.030 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2020 | 237 | 0.030 |
Why?
| | Comorbidity | 1 | 2022 | 1658 | 0.030 |
Why?
| | Endoscopy | 1 | 2020 | 316 | 0.030 |
Why?
| | Postoperative Period | 1 | 2018 | 354 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2021 | 704 | 0.030 |
Why?
| | Lipoproteins, VLDL | 1 | 2016 | 21 | 0.030 |
Why?
| | Risk | 1 | 2019 | 911 | 0.030 |
Why?
| | Africa | 1 | 2017 | 116 | 0.030 |
Why?
| | Body Constitution | 1 | 2016 | 51 | 0.030 |
Why?
| | Young Adult | 3 | 2019 | 14105 | 0.030 |
Why?
| | Arrhythmias, Cardiac | 1 | 2019 | 361 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 634 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2021 | 1030 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2019 | 1370 | 0.030 |
Why?
| | Fellowships and Scholarships | 1 | 2020 | 357 | 0.030 |
Why?
| | Time-to-Treatment | 1 | 2018 | 243 | 0.030 |
Why?
| | Diet, Reducing | 1 | 2016 | 91 | 0.030 |
Why?
| | Birth Weight | 1 | 2019 | 522 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1326 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 365 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2023 | 947 | 0.030 |
Why?
| | Preoperative Care | 1 | 2018 | 379 | 0.030 |
Why?
| | Premature Birth | 1 | 2019 | 380 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2016 | 276 | 0.030 |
Why?
| | Metabolic Diseases | 1 | 2016 | 114 | 0.030 |
Why?
| | Education, Medical | 1 | 2018 | 274 | 0.030 |
Why?
| | Risk Reduction Behavior | 1 | 2016 | 226 | 0.030 |
Why?
| | Military Personnel | 1 | 2022 | 741 | 0.030 |
Why?
| | Databases, Factual | 1 | 2020 | 1486 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 2089 | 0.030 |
Why?
| | Liver | 1 | 2023 | 1887 | 0.030 |
Why?
| | Staphylococcal Infections | 1 | 2018 | 388 | 0.030 |
Why?
| | Fetal Growth Retardation | 1 | 2019 | 587 | 0.020 |
Why?
| | Behavior Therapy | 1 | 2016 | 299 | 0.020 |
Why?
| | Logistic Models | 1 | 2018 | 2117 | 0.020 |
Why?
| | Quality Improvement | 1 | 2021 | 1289 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 2310 | 0.020 |
Why?
| | Primary Health Care | 1 | 2023 | 1733 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1795 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2019 | 1098 | 0.020 |
Why?
| | Parents | 1 | 2019 | 1403 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1273 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2507 | 0.020 |
Why?
|
|
Kaizer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|